{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T19:15:35Z","timestamp":1772046935524,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,1,30]],"date-time":"2021-01-30T00:00:00Z","timestamp":1611964800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,30]],"date-time":"2021-01-30T00:00:00Z","timestamp":1611964800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s12094-020-02528-y","type":"journal-article","created":{"date-parts":[[2021,1,30]],"date-time":"2021-01-30T06:02:43Z","timestamp":1611986563000},"page":"1368-1376","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Characteristics and prognosis of jejunoileal gastrointestinal stromal tumours (GISTs) in the era of imatinib: a comparative study with gastric GISTs"],"prefix":"10.1007","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9448-8657","authenticated-orcid":false,"given":"J. A.","family":"Fern\u00e1ndez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Ferreras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. J.","family":"Ruiz-Manzanera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Olivares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Ferri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. D.","family":"Frutos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,30]]},"reference":[{"key":"2528_CR1","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.canep.2015.10.031","volume":"40","author":"K S\u00f8reide","year":"2015","unstructured":"S\u00f8reide K, Sandvik OM, S\u00f8reide JA, Giljaca V, Jureckova A, Bulusu VR. Global epidemiology of gastrointestinal stromal tumours (GIST): A systematic review of population-based cohort studies. Cancer Epidemiol. 2015;40:39\u201346.","journal-title":"Cancer Epidemiol"},{"issue":"1","key":"2528_CR2","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1158\/1055-9965.EPI-14-1002","volume":"24","author":"GL Ma","year":"2015","unstructured":"Ma GL, Murphy JD, Martinez ME, Sicklick JK. Epidemiology of gastrointestinal stromal tumors in the era of histology codes: results of a population-based study. Cancer Epidemiol Biomarkers Prev. 2015;24(1):298\u2013302.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"3","key":"2528_CR3","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S1470-2045(11)70299-6","volume":"13","author":"H Joensuu","year":"2012","unstructured":"Joensuu H, Vehtari A, Riihim\u00e4ki J, Nishida T, Steigen SE, Brabec P, et al. Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts. Lancet Oncol. 2012;13(3):265\u201374.","journal-title":"Lancet Oncol"},{"issue":"7","key":"2528_CR4","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1245\/s10434-007-9377-9","volume":"14","author":"P Rutkowski","year":"2007","unstructured":"Rutkowski P, Nowecki ZI, Michej W, Debiec-Rychter M, Wo\u017aniak A, Limon J, et al. Risk criteria and prognostic factors for predicting recurrences after resection of primary gastrointestinal stromal tumor. Ann Surg Oncol. 2007;14(7):2018\u201327.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"2528_CR5","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s10434-001-0050-4","volume":"8","author":"JA Crosby","year":"2001","unstructured":"Crosby JA, Catton CN, Davis A, Couture J, O\u2019Sullivan B, Kandel R, et al. Malignant gastrointestinal stromal tumors of the small intestine: a review of 50 cases from a prospective database. Ann Surg Oncol. 2001;8(1):50\u20139.","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"2528_CR6","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1097\/00000478-199704000-00006","volume":"21","author":"JA Brainard","year":"1997","unstructured":"Brainard JA, Goldblum JR. Stromal tumors of the jejunum and ileum: a clinicopathologic study of 39 cases. Am J Surg Pathol. 1997;21(4):407\u201316.","journal-title":"Am J Surg Pathol"},{"key":"2528_CR7","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1471-230X-6-29","volume":"6","author":"T-J Wu","year":"2006","unstructured":"Wu T-J, Lee L-Y, Yeh C-N, Wu P-Y, Chao T-C, Hwang T-L, et al. Surgical treatment and prognostic analysis for gastrointestinal stromal tumors (GISTs) of the small intestine: before the era of imatinib mesylate. BMC Gastroenterol. 2006;6:29.","journal-title":"BMC Gastroenterol"},{"issue":"2","key":"2528_CR8","first-page":"1033","volume":"35","author":"C-H Liao","year":"2015","unstructured":"Liao C-H, Yeh C-N, Wang S-Y, Fu C-Y, Tsai C-Y, Liu Y-Y, et al. Surgical option for intestinal gastrointestinal stromal tumors perioperative and oncological outcomes of laparoscopic surgery. Anticancer Res. 2015;35(2):1033\u201340.","journal-title":"Anticancer Res"},{"issue":"4","key":"2528_CR9","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1097\/00000478-200604000-00008","volume":"30","author":"M Miettinen","year":"2006","unstructured":"Miettinen M, Makhlouf H, Sobin LH, Lasota J. Gastrointestinal stromal tumors of the jejunum and ileum: a clinicopathologic, immunohistochemical, and molecular genetic study of 906 cases before imatinib with long-term follow-up. Am J Surg Pathol. 2006;30(4):477\u201389.","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"2528_CR10","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1007\/s00268-009-9918-4","volume":"33","author":"C-C Huang","year":"2009","unstructured":"Huang C-C, Yang C-Y, Lai I-R, Chen C-N, Lee P-H, Lin M-T. Gastrointestinal stromal tumor of the small intestine: a clinicopathologic study of 70 cases in the postimatinib era. World J Surg. 2009;33(4):828\u201334.","journal-title":"World J Surg"},{"issue":"4","key":"2528_CR11","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1007\/s00268-014-2810-x","volume":"39","author":"IW Han","year":"2015","unstructured":"Han IW, Jang JY, Lee KB, Kang MJ, Kwon W, Park JW, et al. Clinicopathologic analysis of gastrointestinal stromal tumors in duodenum and small intestine. World J Surg. 2015;39(4):1026\u201333.","journal-title":"World J Surg"},{"issue":"2","key":"2528_CR12","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1007\/s00268-014-2824-4","volume":"39","author":"OM Sandvik","year":"2015","unstructured":"Sandvik OM, S\u00f8reide K, Gudlaugsson E, S\u00f8reide JA. Surgery for gastrointestinal stromal tumors (GISTs) of the stomach and small bowel: short and long-term outcomes over three decades. World J Surg. 2015;39(2):446\u201352.","journal-title":"World J Surg"},{"issue":"1","key":"2528_CR13","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s10120-015-0571-3","volume":"20","author":"U Guller","year":"2017","unstructured":"Guller U, Tarantino I, Cerny T, Ulrich A, Schmied BM, Warschkow R. Revisiting a dogma: similar survival of patients with small bowel and gastric GIST. A population-based propensity score SEER analysis. Gastric Cancer. 2017;20(1):49\u201360.","journal-title":"Gastric Cancer"},{"issue":"3","key":"2528_CR14","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1002\/jso.24514","volume":"115","author":"K Giuliano","year":"2017","unstructured":"Giuliano K, Nagarajan N, Canner J, Najafian A, Wolfgang C, Schneider E, et al. Gastric and small intestine gastrointestinal stromal tumors: do outcomes differ? J Surg Oncol. 2017;115(3):351\u20137.","journal-title":"J Surg Oncol"},{"issue":"1","key":"2528_CR15","doi-asserted-by":"publisher","first-page":"10033","DOI":"10.1038\/s41598-019-46520-1","volume":"9","author":"Z Yang","year":"2019","unstructured":"Yang Z, Wang F, Liu S, Guan W. Comparative clinical features and short-term outcomes of gastric and small intestinal gastrointestinal stromal tumours: a retrospective study. Sci Rep. 2019;9(1):10033.","journal-title":"Sci Rep"},{"issue":"3","key":"2528_CR16","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.ejso.2018.09.013","volume":"45","author":"PA Boonstra","year":"2019","unstructured":"Boonstra PA, Steeghs N, Farag S, van Coevorden F, Gelderblom H, Grunhagen D, et al. Surgical and medical management of small bowel gastrointestinal stromal tumors: a report of the Dutch GIST registry. Eur J Surg Oncol. 2019;45(3):410\u20135.","journal-title":"Eur J Surg Oncol."},{"key":"2528_CR17","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1002\/jso.21030","volume":"98","author":"M Everett","year":"2008","unstructured":"Everett M, Gutman H. Surgical management of gastrointestinal stromal tumors: analysis of outcome with respect to surgical margins and technique. J Surg Oncol. 2008;98:588\u201393.","journal-title":"J Surg Oncol"},{"issue":"2","key":"2528_CR18","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1053\/j.semdp.2006.09.001","volume":"23","author":"M Miettinen","year":"2006","unstructured":"Miettinen M, Lasota J. Gastrointestinal stromal tumors: pathology and prognosis at different sites. Semin Diagn Pathol. 2006;23(2):70\u201383.","journal-title":"Semin Diagn Pathol"},{"issue":"5","key":"2528_CR19","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1053\/hupa.2002.123545","volume":"33","author":"CD Fletcher","year":"2002","unstructured":"Fletcher CD, Berman JJ, Corless C, Gorstein F, Lasota J, Longley BJ, et al. Diagnosis of gastrointestinal stromal tumors: A consensus approach. Hum Pathol. 2002;33(5):459\u201365.","journal-title":"Hum Pathol"},{"issue":"6","key":"2528_CR20","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1245\/s10434-010-1496-z","volume":"18","author":"S Patel","year":"2011","unstructured":"Patel S. Navigating risk stratification systems for the management of patients with GIST. Ann Surg Oncol. 2011;18(6):1698\u2013704.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"2528_CR21","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1097\/00000658-200001000-00008","volume":"231","author":"RP DeMatteo","year":"2000","unstructured":"DeMatteo RP, Lewis JJ, Leung D, Mudan SS, Woodruff JM, Brennan MF. Two hundred Gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg. 2000;231(1):51\u20138.","journal-title":"Ann Surg"},{"issue":"8","key":"2528_CR22","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1245\/s10434-008-9969-z","volume":"15","author":"BK Goh","year":"2008","unstructured":"Goh BK, Chow PK, Yap WM, Kesavan SM, Song IC, Paul PG, et al. Which is the optimal risk stratification system for surgically treated localized primary GIST? Comparison of three contemporary prognostic criteria in 171 tumors and a proposal for a modified Armed Forces Institute of Pathology risk criteria. Ann Surg Oncol. 2008;15(8):2153\u201363.","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"2528_CR23","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/S1470-2045(09)70242-6","volume":"10","author":"JS Gold","year":"2009","unstructured":"Gold JS, G\u00f6nen M, Gutierrez A, Broto JM, Garc\u00eda-del Muro X, Smyrk TC, et al. Development and validation of a prognostic nomogram for recurrence-free survival after resection of localised primary gastrointestinal stromal tumor: a retrospective analysis. Lancet Oncol. 2009;10(11):1045\u201352.","journal-title":"Lancet Oncol."},{"issue":"1","key":"2528_CR24","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/s11605-019-04344-4","volume":"24","author":"H Almaazmi","year":"2020","unstructured":"Almaazmi H, Stem M, Lo BD, Taylor JP, Fang SH, Safar B, et al. The impact of imatinib on survival and treatment trends for small bowel and colorectal gastrointestinal stromal tumors. J Gastrointest Surg. 2020;24(1):98\u2013108.","journal-title":"J Gastrointest Surg"},{"key":"2528_CR25","doi-asserted-by":"publisher","unstructured":"ESMO Guidelines Committee. Appendix 3: Soft tissue sarcoma: MCBS eUpdate published online 5 May 2017 (www.esmo.org\/Guidelines\/Sarcoma-and-GIST).\u00a0Ann Oncol. 2017;28(suppl_4):iv147\u201348. https:\/\/doi.org\/10.1093\/annonc\/mdx241.","DOI":"10.1093\/annonc\/mdx241"},{"issue":"Suppl 2","key":"2528_CR26","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.6004\/jnccn.2007.2002","volume":"5","author":"GD Demetri","year":"2007","unstructured":"Demetri GD, Benjamin RS, Blanke CD, Blay JY, Casali P, Choi H, et al. NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST)\u2013update of the NCCN clinical practice guidelines. J Natl Compr Canc Netw. 2007;5(Suppl 2):S1\u201330.","journal-title":"J Natl Compr Canc Netw"},{"issue":"12","key":"2528_CR27","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1007\/s12094-016-1579-9","volume":"18","author":"A Poveda","year":"2016","unstructured":"Poveda A, Martinez V, Serrano C, Sevilla I, Lecumberri MJ, de Beveridge RD, et al. SEOM Clinical Guideline for gastrointestinal sarcomas (GIST). Clin Transl Oncol. 2016;18(12):1221\u20138.","journal-title":"Clin Transl Oncol"},{"issue":"36","key":"2528_CR28","doi-asserted-by":"publisher","first-page":"4276","DOI":"10.1200\/JCO.2015.62.4304","volume":"33","author":"PG Casali","year":"2015","unstructured":"Casali PG, Le Cesne A, Poveda Velasco A, Kotasek D, Rutkowski P, Hohenberger P, et al. Time to definitive failure to the first tyrosine kinase inhibitor in localized gi stromal tumors treated with imatinib as an adjuvant: a European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Intergroup Randomized Trial in Collaboration With the Australasian Gastro-Intestinal Trials Group, UNICANCER, French Sarcoma Group, Italian Sarcoma Group, and Spanish Group for Research on Sarcomas. J Clin Oncol. 2015;33(36):4276\u201383.","journal-title":"J Clin Oncol"},{"issue":"12","key":"2528_CR29","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1001\/jama.2012.347","volume":"307","author":"H Joensuu","year":"2012","unstructured":"Joensuu H, Eriksson M, Sundby Hall K, Hartmann JT, Pink D, Schutte J, et al. One vs three years of adjuvant imatinib for operable gastrointestinal stromal tumor: a randomized trial. JAMA. 2012;307(12):1265\u201372.","journal-title":"JAMA"},{"issue":"4","key":"2528_CR30","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s00432-016-2334-x","volume":"143","author":"JX Lin","year":"2017","unstructured":"Lin JX, Chen QF, Zheng CH, Li P, Xie JW, Wang JB, et al. Is 3-years duration of adjuvant imatinib mesylate treatment sufficient for patients with high-risk gastrointestinal stromal tumor? A study based on long-term follow-up. J Cancer Res Clin Oncol. 2017;143(4):727\u201334.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"2528_CR31","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1136\/flgastro-2015-100670","volume":"8","author":"MJ McDonnell","year":"2017","unstructured":"McDonnell MJ, Punnoose S, Viswanath YKS, Wadd NJ, Dhar A. Gastrointestinal stromal tumours (GISTs): an insight into clinical practice with review of literature. Front Gastroenterol. 2017;8(1):19\u201325.","journal-title":"Front Gastroenterol"},{"issue":"3","key":"2528_CR32","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.gtc.2016.04.006","volume":"45","author":"V Mart\u00ednez-Mar\u00edn","year":"2016","unstructured":"Mart\u00ednez-Mar\u00edn V, Maki RG. Knowns and known unknowns of gastrointestinal stromal tumor adjuvant therapy. Gastroenterol Clin N Am. 2016;45(3):477\u201386.","journal-title":"Gastroenterol Clin N Am"},{"key":"2528_CR33","unstructured":"Three Versus Five Years of Adjuvant Imatinib as Treatment of Patients With Operable GIST. ClinicalTrials.gov. Identifier: NCT02413736"},{"key":"2528_CR34","doi-asserted-by":"crossref","unstructured":"Patel DJ, Lutfi W, Eguia E, Sweigert P, Knab L, Abood G, et al. Adjuvant systemic therapy for small bowel gastrointestinal stromal tumor (GIST): is there a survival benefit after R0 resection?\u00a0Surgery. 2020.","DOI":"10.1016\/j.surg.2020.04.069"},{"issue":"8","key":"2528_CR35","doi-asserted-by":"publisher","first-page":"8147","DOI":"10.18632\/oncotarget.23692","volume":"9","author":"H Ye","year":"2017","unstructured":"Ye H, Xin H, Zheng Q, Shen Q, Dai W, Wu F, et al. Prognostic role of the primary tumour site in patients with operable small intestine and gastrointestinal stromal tumours: a large population-based analysis. Oncotarget. 2017;9(8):8147\u201354.","journal-title":"Oncotarget"},{"issue":"3","key":"2528_CR36","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/jso.25172","volume":"118","author":"K Giuliano","year":"2018","unstructured":"Giuliano K, Ejaz A, Reames BN, Choi W, Sham J, Gage M, et al. Comparing the long-term outcomes among patients with stomach and small intestine gastrointestinal stromal tumors: An analysis of the National Cancer Database. J Surg Oncol. 2018;118(3):486\u201392.","journal-title":"J Surg Oncol"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-020-02528-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-020-02528-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-020-02528-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T18:39:54Z","timestamp":1697740794000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-020-02528-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,30]]},"references-count":36,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["2528"],"URL":"https:\/\/doi.org\/10.1007\/s12094-020-02528-y","relation":{},"ISSN":["1699-048X","1699-3055"],"issn-type":[{"value":"1699-048X","type":"print"},{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,30]]},"assertion":[{"value":"31 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors of this manuscript have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All of the procedures carried out in studies with human participants were in accordance with the ethical standards of the institutional and\/or national research committee and the Declaration of Helsinki of 1964 and its subsequent modifications or comparable ethical standards. The study was approved by the Ethics Committee of the \u201cLa Arrixaca\u201d University Hospital in Murcia.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"For this type of study formal consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}